The court has, however, allowed Glenmark to continue to sell existing inventory, the sources said. 
Special 
The court has, however, allowed Glenmark to continue to sell existing inventory, the sources said. The Supreme Court has blocked Glenmark Pharmaceuticals Ltd (GLEN.NS) from selling copies of US drugmaker Merck & Co Inc's (MRK.N) diabetes drugs Januvia and Janumet, sources with knowledge of the matter said after a court hearing on Friday.
The court has, however, allowed Glenmark to continue to sell existing inventory, the sources said.
Merck sued Glenmark in 2013 for infringing a patent it has on sitagliptin, the chemical compound in Januvia and Janumet. Glenmark sells the medicines under the brand names Zita and Zita-met.
(Reuters)
Copyright©2025 Living Media India Limited. For reprint rights: Syndications Today
